Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.01 HKD
45.62 M HKD
1.07 B HKD
584.74 M
About KINDSTAR GLOBALGENE TECHNOLOGY INC
Sector
Industry
CEO
Shi Ang Huang
Website
Headquarters
Wuhan
Founded
2007
FIGI
BBG00ZF3HWC7
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. It operates through the following segments: Hematology Testing, Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, COVID-19 Related Testing, Routine Testing, and Others. The Others segment includes testing services for research and development projects, and others and miscellaneous services. The company was founded on August 24, 2007 and is headquartered in Wuhan, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 9960 is 1.12 HKD — it hasn't changed in the past 24 hours. Watch KINDSTAR GLOBALGENE TECHNOLOGY INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange KINDSTAR GLOBALGENE TECHNOLOGY INC stocks are traded under the ticker 9960.
9960 stock hasn't changed in a week, the month change is a −4.27% fall, over the last year KINDSTAR GLOBALGENE TECHNOLOGY INC has showed a −31.29% decrease.
9960 reached its all-time high on Jul 16, 2021 with the price of 9.78 HKD, and its all-time low was 0.93 HKD and was reached on Sep 10, 2024. View more price dynamics on 9960 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
9960 stock is 1.82% volatile and has beta coefficient of 0.57. Track KINDSTAR GLOBALGENE TECHNOLOGY INC stock price on the chart and check out the list of the most volatile stocks — is KINDSTAR GLOBALGENE TECHNOLOGY INC there?
Today KINDSTAR GLOBALGENE TECHNOLOGY INC has the market capitalization of 1.06 B, it has decreased by −0.88% over the last week.
Yes, you can track KINDSTAR GLOBALGENE TECHNOLOGY INC financials in yearly and quarterly reports right on TradingView.
KINDSTAR GLOBALGENE TECHNOLOGY INC is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
9960 earnings for the last half-year are 0.01 HKD per share, whereas the estimation was 0.06 HKD, resulting in a −81.15% surprise. The estimated earnings for the next half-year are 0.06 HKD per share. See more details about KINDSTAR GLOBALGENE TECHNOLOGY INC earnings.
KINDSTAR GLOBALGENE TECHNOLOGY INC revenue for the last half-year amounts to 463.81 M HKD, despite the estimated figure of 650.46 M HKD. In the next half-year revenue is expected to reach 698.14 M HKD.
9960 net income for the last half-year is 12.89 M HKD, while the previous report showed −2.91 M HKD of net income which accounts for 542.55% change. Track more KINDSTAR GLOBALGENE TECHNOLOGY INC financial stats to get the full picture.
Yes, 9960 dividends are paid annually. The last dividend per share was 0.03 HKD. As of today, Dividend Yield (TTM)% is 2.54%. Tracking KINDSTAR GLOBALGENE TECHNOLOGY INC dividends might help you take more informed decisions.
KINDSTAR GLOBALGENE TECHNOLOGY INC dividend yield was 1.69% in 2023, and payout ratio reached 59.66%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 3.13 K employees. See our rating of the largest employees — is KINDSTAR GLOBALGENE TECHNOLOGY INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KINDSTAR GLOBALGENE TECHNOLOGY INC EBITDA is −2.63 M HKD, and current EBITDA margin is 0.53%. See more stats in KINDSTAR GLOBALGENE TECHNOLOGY INC financial statements.
Like other stocks, 9960 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KINDSTAR GLOBALGENE TECHNOLOGY INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KINDSTAR GLOBALGENE TECHNOLOGY INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KINDSTAR GLOBALGENE TECHNOLOGY INC stock shows the sell signal. See more of KINDSTAR GLOBALGENE TECHNOLOGY INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.